No Data
No Data
The 15.92% Average Gain in Inauguration Year: Will Trump's Second Term Echo the Trend?
Here's How Much You Would Have Made Owning UnitedHealth Group Stock In The Last 10 Years
Don't Buy Weight-Loss Medication From Unauthorized Sources, UK Health Agency Warns About Risks
Here's How Much $1000 Invested In Boston Scientific 10 Years Ago Would Be Worth Today
Weight Loss Drugs Can Cut Grocery Spending by up to 9%: Study
Insurance is not covered, supply shortages, rampant generic drugs, slow new drug development, and new weight-loss medications still face challenges.
New GLP-1 weight loss drugs are not only changing the lives of obese populations but also creating billions of dollars in revenue for pharmaceutical companies like Eli Lilly and Co and Novo-Nordisk A/S. However, analysis indicates that weight loss drugs currently face some challenges in the USA: there is the risk of insurance companies refusing to pay, and ongoing supply shortages have created opportunities for lower-priced generic drugs. Additionally, it remains uncertain whether pharmaceutical companies can truly develop better weight loss medications and what the new U.S. government's attitude toward weight loss drugs will be.
A1EIIWLU1C : Funny, as I came here to add a comment about my annoyance with the word disruptive. "Innovative" used to do the trick, but apparently that isn't edgy enough.
oXrssHBsXw : Marketing-wise, this reminds me of the “Internet Tollkeeper Fund (GITAX)” I bought in ‘99. Fees were brutal.
Baby u : As GS shareholder I love it, 75 BPS ca-ching!, will not use it but there are plenty of managers and clients with plenty of cash who will.